UHPLC determination of oligonucleotide purity

contributed by YMC | 02/16/2023

Oligonucleotides are a rising class of drugs which have entered the market as biopharmaceuticals due to their ability to interfere directly with gene expression instead of targeting the protein. The production of oligonucleotides is usually conducted by chemical solid-phase synthesis and use of nucleoside phosphoramidites as building blocks. To prevent undesired side reactions, protecting groups are attached to the nucleosides, for example the 5’-hydroxy group of the sugar moiety is protected with a dimethoxytrityl (DMT) group.

Log in or register to read this article in full and gain access to The Analytical Scientist’s entire content archive. It’s FREE!

Email*

Choose a password

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

Receive communication from The Cannabis Scientist I want to stay up to date with the Mass Spectrometry field I want to stay up to date with the Spectroscopy field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.